NOV 04, 2020 10:14 AM PST

Building a New Chemotherapy Drug

WRITTEN BY: Jasper Cantrell

For decades, modern medicine has relied on chemists’ work to produce compounds that could one day be used as a drug for one disease or another. Through the use of a little mad science, these chemists helped advance medicine into the modern age.

Anti-cancer medicine is one such field where chemists were some of the primary contributors to drugs and therapies for decades. What chemists do is combine different molecules in controlled reactions to produce (they hope) a specific kind of molecule. These molecules are intended to fit into important binding sites within the cellular machinery and inhibit or activate some pathways to fight back against a disease.

One example of chemistry in modern medicine is chemotherapy. Chemotherapy is a treatment method that uses chemical compounds designed to target a particular protein abundant in cancer cells. Once the chemical reaches the protein, it would bind to and inhibit the protein and impair the cancer’s growth.

So how do they do it? Well, there are easily thousands of different reactions chemists could use to make any number of molecules. In one new study, a team at the University of Minnesota used base molecules indazole and diphenyl urea to produce a series of molecules to design a new anti-cancer drug.

Honestly, it is hard to relate chemistry and the reactions the team conducted to get the final molecules, so if you are interested, please click on the link at the end of the article to see the specifics (pages 2 and 3). After a few rounds of reactions, the team ended up with eleven candidates that all showed anti-cancer activity against several aggressive cancer cell lines in vitro. However, the team came across stability issues and, after some work, ended up with only two final candidates.

These candidates retained the in vitro anti-cancer abilities of the most effective of the original eleven molecules while being sufficiently stable to proceed with testing. The team ran a mouse model to investigate these molecules’ effects on mice and against tumor growth. The molecules proved to be well tolerated (little to no toxicity) in mice and inhibited tumors’ growth compared to controls. They were even more effective than approved chemotherapies oxaliplatin and doxorubicin.

Modern medicine might be all about these new-fangled biological drugs, but don’t count the chemists out yet. This study identified two molecules that showed significant anti-cancer activity both in vitro and in mouse models. The molecules even outdid current clinical chemotherapies (in the mouse model).  More information is needed on the safety of the molecules, but these results are quite promising.

The study concludes, “Further structure activity relationship studies are required to synthesize and identify a more potent lead compound that can completely suppress the tumor growth, wherein detailed mechanism of action studies can be carried out.”

Sources: Nature Scientific Reports, It's Okay To Be Smart

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
MAY 15, 2021
Cancer
What does your polygenic risk score mean?
MAY 15, 2021
What does your polygenic risk score mean?
A study published in The American Journal of Clinical Nutrition recommends that people with a high polygenic risk score ...
JUN 10, 2021
Cell & Molecular Biology
Does Lithium Prevent Colon Cancer?
JUN 10, 2021
Does Lithium Prevent Colon Cancer?
Researchers found that a drug used in the treatment of mental illness can promote the fitness of healthy gut stem cells, ...
JUN 27, 2021
Cancer
Are e-cigarettes actually helpful for smoking cessation?
JUN 27, 2021
Are e-cigarettes actually helpful for smoking cessation?
New research published in The Lancet Public Health reports on a study that looked at interventions targeting e-cigarette ...
JUL 30, 2021
Cancer
Obesity Reduces Mortality in Advanced Prostate Cancer
JUL 30, 2021
Obesity Reduces Mortality in Advanced Prostate Cancer
Obese patients with an advanced form of prostate cancer survive longer than their slimmer counterparts, according to res ...
AUG 29, 2021
Cancer
Blood Test over 90% Accurate in Detecting Lung Cancer
AUG 29, 2021
Blood Test over 90% Accurate in Detecting Lung Cancer
An AI-powered blood test was able to correctly detect the presence of lung cancer over 90% of the time in patient sample ...
SEP 20, 2021
Cancer
An Established Ovarian Cancer Antigen Presents a Promising Therapeutic Target
SEP 20, 2021
An Established Ovarian Cancer Antigen Presents a Promising Therapeutic Target
For the past several decades, cancer antigen 125 (CA 125), a protein located on the surface of ovarian cancer cells, has ...
Loading Comments...